No abstract

Objectives The purpose of this study was to compare the efficacy of integrated cognitive behavioral therapy with Transdiagnostic Treatment on symptoms of patients with generalized anxiety disorder comorbid with depression. Methods The quasi-experimental design of two groups (integrated cognitive behavioral therapy group, Transdiagnostic treatment group) was used for competitive validity. The statistical population included people with comorbid anxiety disorder with depression who referred to counseling centers in Isfahan in 1398, from which 10 people were selected by purposive sampling and randomly assigned to two groups. Research instruments were GAD-7 scales, Beck Depression Inventory, and Penn State Worry Questionnaire (PSWQ). Results Visual charting, percentage of improvement, and reliable change index (RCI)) showed that both treatments produced clinically and statistically significant changes in therapeutic outcomes (symptoms of anxiety, worry and depressive symptoms) and continued therapeutic effects during follow-up. But the percentages of improvement in the integrated treatment group in all three components of symptoms of anxiety, worry and depression were higher. Conclusion Based on the obtained results and based on the Theoretical explanation of findings for effectiveness of therapy, integrated Cognitive Behavioral Therapy is preferred over transdiagnostic treatment in terms of the magnitude of change and stability, but both are similar in acceptance.

No abstract

Objective: This study aims to investigate the effectiveness of transdiagnostic treatment on maladaptive personality traits and mentalized affectivity of patients with generalized anxiety disorder comorbid with depression. Methods: This was a quasi-experimental study with a single case method. The statistical population included people with generalized anxiety disorder comorbid with depression who were referred to counseling centers in Isfahan City, Iran in 2020. From this population, 5 people were selected via purposive sampling and they were intervened with transdiagnostic treatment through weekly sessions held individually. The subjects were assessed at the baseline, third, fifth, eighth, and tenth sessions, and during a 1-month follow-up period using the short version of the adult version of the diagnostic and statistical manual of mental disorders, fifth edition, personality questionnaire, and the mentalized affectivity scale. To report the data, we used visual analysis, reliable change index, improvement percentage, and statistical and clinical significance. Results: The visual analysis, percentage of improvement, and reliable change index (RCI≥1/96), showed that transdiagnostic treatment created statistically significant changes and improvement in mentalized affectivity components, negative affectivity, and detachment; however, it did not have a significant effect on other personality traits (antagonism, disinhibition, and psychoticism). Conclusion: Transdiagnostic treatment is an effective treatment to modulate the mentalized affectivity, negative affectivity, and detachment of people with generalized anxiety disorder comorbid with depression.

No abstract